Regeneron's Reckoning.

The article discusses various aspects of the Tarrytown, New York-based Regeneron Pharmaceuticals Inc. (Regeneron) firm which is led by cofounder Leonard Schleifer, and it mentions Schleifer's criticism of the pricing practices at other drug companies. The costs associated with Regeneron's Eylea eye drug and Dupixent eczema medication are examined, along with scientist George Yancopoulos who is also one of Regeneron's cofounders. Business revenue and stock share prices are assessed.